AnalystsSteven SeedhouseSteven Seedhouse's Stock Forecasts
AnalystsSteven Seedhouse
Analyst Ranking
Bottom 6%
#3400 out of 3583 analysts
Average Return
-5.4%
Win Rate
35%19 out of 55
Risk vs Reward
Poor
Good
Steven Seedhouse's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Editas Medicine IncEDIT | +331.74% | $20.98 | $90.58 | 2020-02-26 - 2021-01-08 | Buy |
ChemoCentryx IncCCXI | +142.26% | $10.46 | $25.34 | 2021-05-06 - 2022-01-25 | Buy |
Kadmon Holdings IncKDMN | +106.07% | $4.61 | $9.50 | 2021-03-04 - 2021-11-09 | Buy |
Ngm Biopharmaceuticals IncNGM | +86.12% | $14.19 | $26.41 | 2020-04-06 - 2021-04-07 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +74.60% | $24.80 | $43.30 | 2020-03-31 - 2021-04-01 | Strong Buy |
Steven Seedhouse's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirum Pharmaceuticals IncMIRM | 4 | Strong Buy | $70.00 | +295.03% | Maintains | 15 days ago |
Apellis Pharmaceuticals IncAPLS | 4 | Strong Buy | $112.00 | +182.33% | Maintains | 16 days ago |
NexImmune IncNEXI | 1 | Buy | $21.00 | +521.30% | Maintains | 2 months ago |
CymaBay Therapeutics IncCBAY | 2 | Strong Buy | $14.00 | +376.19% | Maintains | 2 months ago |
ChemoCentryx IncCCXI | 5 | Strong Buy | $110.00 | +334.10% | Maintains | 3 months ago |
InflaRx NVIFRX | 4 | Strong Buy | $15.00 | +334.78% | Maintains | 3 months ago |
Ngm Biopharmaceuticals IncNGM | 6 | Strong Buy | $42.00 | +183.98% | Maintains | 3 months ago |
Jounce Therapeutics IncJNCE | 5 | Buy | $15.00 | +121.89% | Maintains | 3 months ago |
Intercept Pharmaceuticals IncICPT | 3 | Buy | $44.00 | +186.09% | Maintains | 3 months ago |
Leap Therapeutics IncLPTX | 1 | Buy | $4.00 | +102.02% | Maintains | 4 months ago |
89bio IncETNB | 2 | Buy | $33.00 | +298.07% | Maintains | 5 months ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Sell | N/A | N/A | Downgrades | 5 months ago |
Intellia Therapeutics IncNTLA | 2 | Buy | $181.00 | +113.52% | Maintains | 6 months ago |
Catalyst Biosciences IncCBIO | 1 | Buy | $18.00 | +2,971.67% | Maintains | 6 months ago |
Landos Biopharma IncLABP | 2 | Buy | $35.00 | +872.22% | Maintains | 6 months ago |
Viking Therapeutics IncVKTX | 6 | Buy | $13.00 | +266.20% | Maintains | 6 months ago |
Kadmon Holdings IncKDMN | 1 | Buy | $10.00 | +5.26% | Maintains | a year ago |
Editas Medicine IncEDIT | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Alexion Pharmaceuticals IncALXN | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Gilead Sciences IncGILD | 3 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Biogen IncBIIB | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.